OncoSec

-$0.03 (-1.71%) As of 3:00 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OncoSec and other ETFs, options, and stocks.

About ONCS

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.

CEO
Brian A. Leuthner, MBA
Employees
46
Headquarters
Pennington, New Jersey
Founded
2008

ONCS Key Statistics

Market Cap
67.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
289.58K
High Today
$1.78
Low Today
$1.72
Open Price
$1.78
Volume
34.08K
52 Week High
$8.16
52 Week Low
$1.65

ONCS Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Dec 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure